SCHEMBL25539872

SCHEMBL25539872

CC1(C)c2cc(-c3ccc(-c4ccc(-c5nc(-c6ccccc6)cc(-c6ccc(-c7ccccc7)cc6)n5)c5ccccc45)cc3)ccc2-c2c1ccc1ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 3/20 0.37
KDM4E B2RXH2 2/20 0.37
ACACA Q13085 2/20 0.36
CYP1A1 P04798 1/20 0.35
CYP1B1 Q16678 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
NTSR1 P30989 1/20 0.34
ENPP3 O14638 1/20 0.34
ENPP1 P22413 1/20 0.34
GPR84 Q9NQS5 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
PTGES O14684 1/20 0.33
DHODH Q02127 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25539868 1.00 MAPT (0.37) MAPTALDH1A1HPGDKDM4EACACA
SCHEMBL25539876 0.97 CYP1A1 (0.35) MAPTALDH1A1HPGDKDM4EACACA
SCHEMBL25540346 0.96 CYP1A1 (0.35) MAPTALDH1A1HPGDKDM4EACACA
SCHEMBL25538682 0.96 CYP1A1 (0.35) MAPTALDH1A1HPGDKDM4EACACA
SCHEMBL25538687 0.96 CYP1A1 (0.35) MAPTALDH1A1HPGDKDM4EACACA
SCHEMBL25539886 0.96 CYP1A1 (0.42) MAPTALDH1A1HPGDKDM4EACACA
SCHEMBL25538782 0.95 RARA (0.34) MAPTALDH1A1HPGDKDM4EACACA
SCHEMBL25540034 0.95 RARA (0.34) MAPTALDH1A1HPGDKDM4EACACA
SCHEMBL25540187 0.95 CYP1A1 (0.35) MAPTALDH1A1HPGDKDM4EACACA
SCHEMBL25538679 0.95 CYP1A1 (0.36) MAPTALDH1A1HPGDKDM4EACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MAPT 1595/4885ALDH1A1 254/4885HPGD 3854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.